Journal for ImmunoTherapy of Cancer (Jan 2022)

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial

  • David Cibula,
  • Pawel Knapp,
  • Bohuslav Melichar,
  • Jiřina Bartůňková,
  • Radek Špíšek,
  • Lukas Rob,
  • Jitka Fucikova,
  • Peter Mallmann,
  • Lubos Minar,
  • Marek Pluta,
  • Jaroslav Klát,
  • Jirí Špacek,
  • Pavel Bartos,
  • Josef Chovanec,
  • Petr Valha,
  • Zdenek Novotny,
  • Dariusz Kieszko,
  • Tereza Hrnciarova,
  • Roman Pawel Korolkiewicz,
  • Marek Hraska

DOI
https://doi.org/10.1136/jitc-2021-003190
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

No abstracts available.